Annick Moens

Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti‐TNF or conventional therapy: results of the European CONCEIVE study

Annick Moens, C. Janneke van der Woude, Mette Julsgaard et al. · Alimentary Pharmacology & Therapeutics · 2019 · 138 citations · Full text

Medicine, Immunology, Obstetrics +14

Perioperative Use of Vedolizumab is not Associated with Postoperative Infectious Complications in Patients with Ulcerative Colitis Undergoing Colectomy

Marc Ferrante, Anthony de Buck van Overstraeten, Nikkie Schils et al. · Journal of Crohn s and Colitis · 2017 · 67 citations · Full text

Medicine, Perioperative Medicine, Surgery +12

Outcome of Pregnancies in Female Patients With Inflammatory Bowel Diseases Treated With Vedolizumab

Annick Moens, Karen van Hoeve, Evelien Humblet et al. · Journal of Crohn s and Colitis · 2018 · 56 citations · Full text

Medicine, Immunology, Obstetrics +13

Long‐term outcomes of patients with ulcerative proctitis: Analysis from a large referral centre cohort

E Dubois, Annick Moens, R Geelen et al. · United European Gastroenterology Journal · 2020 · 34 citations · Full text

Medicine, Internal Medicine, End-of-life Care +10

Translating Results from VARSITY to Real World: Adalimumab vs Vedolizumab as First-line Biological in Moderate to Severe IBD

Annick Moens, Bram Verstockt, Dahham Alsoud et al. · Inflammatory Bowel Diseases · 2021 · 21 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +15